AIQ Solutions

Executive Summary

AIQ Solutions is a privately held digital health company based in Cambridge, MA, focused on precision oncology through its software medical device, TRAQinform IQ. Founded in 2018, the company offers a novel platform that quantifies changes in regions of interest (e.g., tumors) over time using medical imaging data. This enables oncologists to more precisely adjust therapies and optimize clinical outcomes. TRAQinform IQ differentiates itself by providing objective, longitudinal measurement of disease progression or response, potentially improving treatment decisions over subjective assessments. The company operates in the AI/machine learning and diagnostics sectors. As a pre-revenue or early-stage entity, valuation metrics are unavailable, but the technology addresses a clear unmet need in cancer care: better monitoring of therapy effectiveness. Success hinges on clinical validation, regulatory clearance, and commercial adoption. With no disclosed funding rounds or partnerships, the company appears to be in early development. However, its focus on AI-driven quantitative imaging positions it within a high-growth segment of precision medicine.

Upcoming Catalysts (preview)

• Q4 2026FDA 510(k) clearance or CE marking for TRAQinform IQ60% success
• Q1 2027Publication of pivotal clinical study results demonstrating improved patient outcomes50% success
• H2 2026Strategic partnership or licensing agreement with a major imaging or oncology company40% success